{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:38:26Z","timestamp":1794620306850,"version":"4.9.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20728"],"award-info":[{"award-number":["20728"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["21812"],"award-info":[{"award-number":["21812"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["strategic MyoNeurALP alliance"],"award-info":[{"award-number":["strategic MyoNeurALP alliance"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The absence of dystrophin in Duchenne muscular dystrophy disrupts the dystrophin-associated glycoprotein complex resulting in skeletal muscle fiber fragility and atrophy, associated with fibrosis as well as microtubule and neuromuscular junction disorganization. The specific, non-conventional cytoplasmic histone deacetylase 6 (HDAC6) was recently shown to regulate acetylcholine receptor distribution and muscle atrophy. Here, we report that administration of the HDAC6 selective inhibitor tubastatin A to the Duchenne muscular dystrophy,\n                    <jats:italic>mdx<\/jats:italic>\n                    mouse model increases muscle strength, improves microtubule, neuromuscular junction, and dystrophin-associated glycoprotein complex organization, and reduces muscle atrophy and fibrosis. Interestingly, we found that the beneficial effects of HDAC6 inhibition involve the downregulation of transforming growth factor beta signaling. By increasing Smad3 acetylation in the cytoplasm, HDAC6 inhibition reduces Smad2\/3 phosphorylation, nuclear translocation, and transcriptional activity. These findings provide in vivo evidence that Smad3 is a new target of HDAC6 and implicate HDAC6 as a potential therapeutic target in Duchenne muscular dystrophy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-34831-3","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T07:03:11Z","timestamp":1668841391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-\u03b2 via Smad3 acetylation"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-5785","authenticated-orcid":false,"given":"Alexis","family":"Osseni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-7372","authenticated-orcid":false,"given":"Aymeric","family":"Ravel-Chapuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Scionti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-1184","authenticated-orcid":false,"given":"Yann-Ga\u00ebl","family":"Gangloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Moncollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Mazelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-4475","authenticated-orcid":false,"given":"Bernard J.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-503X","authenticated-orcid":false,"given":"Laurent","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"34831_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.23982","volume":"74","author":"JR Mendell","year":"2013","unstructured":"Mendell, J. R. et al. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann. Neurol. 74, 637\u2013647 (2013).","journal-title":"Ann. Neurol."},{"key":"34831_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","volume":"21","author":"SJ Moat","year":"2013","unstructured":"Moat, S. J., Bradley, D. M., Salmon, R., Clarke, A. & Hartley, L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur. J. Hum. Genet 21, 1049\u20131053 (2013).","journal-title":"Eur. J. Hum. Genet"},{"key":"34831_CR3","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S1474-4422(16)30035-7","volume":"15","author":"V Straub","year":"2016","unstructured":"Straub, V. et al. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy. Lancet Neurol. 15, 882\u2013890 (2016).","journal-title":"Lancet Neurol."},{"key":"34831_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jnnp-2016-315106.142","volume":"87","author":"V Ricotti","year":"2016","unstructured":"Ricotti, V. et al. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials. J. Neurol. Neurosurg. Psychiatry 87, 149\u2013155 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"34831_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AEH Emery","year":"2002","unstructured":"Emery, A. E. H. The muscular dystrophies. Lancet 359, 687\u2013695 (2002).","journal-title":"Lancet"},{"key":"34831_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/0883073814558120","volume":"30","author":"S Kim","year":"2015","unstructured":"Kim, S. et al. Corticosteroid treatments in males with duchenne muscular dystrophy: treatment duration and time to loss of ambulation. J. Child Neurol. 30, 1275\u20131280 (2015).","journal-title":"J. Child Neurol."},{"key":"34831_CR7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"25","author":"RT Moxley","year":"2010","unstructured":"Moxley, R. T., Pandya, S., Ciafaloni, E., Fox, D. J. & Campbell, K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J. Child Neurol. 25, 1116\u20131129 (2010).","journal-title":"J. Child Neurol."},{"key":"34831_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","volume":"66","author":"JM Ervasti","year":"1991","unstructured":"Ervasti, J. M. & Campbell, K. P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121\u20131131 (1991).","journal-title":"Cell"},{"key":"34831_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti, J. M. & Campbell, K. P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809\u2013823 (1993).","journal-title":"J. Cell Biol."},{"key":"34831_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1083\/jcb.200905048","volume":"186","author":"KW Prins","year":"2009","unstructured":"Prins, K. W. et al. Dystrophin is a microtubule-associated protein. J. Cell Biol. 186, 363\u2013369 (2009).","journal-title":"J. Cell Biol."},{"key":"34831_CR11","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.1073\/pnas.1512991112","volume":"112","author":"JF Garbincius","year":"2015","unstructured":"Garbincius, J. F. & Michele, D. E. Dystrophin\u2013glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling. Proc. Natl Acad. Sci. USA 112, 13663\u201313668 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34831_CR12","doi-asserted-by":"publisher","first-page":"12140","DOI":"10.1021\/acsnano.8b05721","volume":"12","author":"S Le","year":"2018","unstructured":"Le, S. et al. Dystrophin as a molecular shock absorber. ACS Nano 12, 12140\u201312148 (2018).","journal-title":"ACS Nano"},{"key":"34831_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-510X(90)90005-8","volume":"100","author":"B Weller","year":"1990","unstructured":"Weller, B., Karpati, G. & Carpenter, S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100, 9\u201313 (1990).","journal-title":"J. Neurol. Sci."},{"key":"34831_CR14","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710\u20133714 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34831_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1014587918367","volume":"22","author":"C Dellorusso","year":"2001","unstructured":"Dellorusso, C., Crawford, R. W., Chamberlain, J. S. & Brooks, S. V. Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J. Muscle Res Cell Motil. 22, 467\u2013475 (2001).","journal-title":"J. Muscle Res Cell Motil."},{"key":"34831_CR16","doi-asserted-by":"publisher","first-page":"C1430","DOI":"10.1152\/ajpcell.00192.2010","volume":"299","author":"JD Gumerson","year":"2010","unstructured":"Gumerson, J. D., Kabaeva, Z. T., Davis, C. S., Faulkner, J. A. & Michele, D. E. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Am. J. Physiol. Cell Physiol. 299, C1430\u20131440 (2010).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"34831_CR17","doi-asserted-by":"publisher","first-page":"C661","DOI":"10.1152\/ajpcell.00061.2007","volume":"293","author":"C Alexakis","year":"2007","unstructured":"Alexakis, C., Partridge, T. & Bou-Gharios, G. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am. J. Physiol. Cell Physiol. 293, C661\u2013669 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"34831_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gad.465908","volume":"22","author":"B Vidal","year":"2008","unstructured":"Vidal, B. et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta\/alternative macrophage activation pathway. Genes Dev. 22, 1747\u20131752 (2008).","journal-title":"Genes Dev."},{"key":"34831_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/hmg\/ddn376","volume":"18","author":"SA Villalta","year":"2009","unstructured":"Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T. & Tidball, J. G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet 18, 482\u2013496 (2009).","journal-title":"Hum. Mol. Genet"},{"key":"34831_CR20","doi-asserted-by":"publisher","first-page":"e46698","DOI":"10.1371\/journal.pone.0046698","volume":"7","author":"P-F Lesault","year":"2012","unstructured":"Lesault, P.-F. et al. Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One 7, e46698 (2012).","journal-title":"PLoS One"},{"key":"34831_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2332-4","volume":"11","author":"M Saclier","year":"2020","unstructured":"Saclier, M. et al. Nutritional intervention with cyanidin hinders the progression of muscular dystrophy. Cell Death Dis. 11, 127 (2020).","journal-title":"Cell Death Dis."},{"key":"34831_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.omtn.2017.12.008","volume":"10","author":"C Domenger","year":"2018","unstructured":"Domenger, C. et al. RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect. Mol. Ther. Nucleic Acids 10, 277\u2013291 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"34831_CR23","doi-asserted-by":"publisher","first-page":"eaap9004","DOI":"10.1126\/sciadv.aap9004","volume":"4","author":"C Long","year":"2018","unstructured":"Long, C. et al. Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci. Adv. 4, eaap9004 (2018).","journal-title":"Sci. Adv."},{"key":"34831_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/hmg\/ddv444","volume":"25","author":"C P\u00e9ladeau","year":"2016","unstructured":"P\u00e9ladeau, C. et al. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles. Hum. Mol. Genet 25, 24\u201343 (2016).","journal-title":"Hum. Mol. Genet"},{"key":"34831_CR25","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1096\/fj.201800081R","volume":"32","author":"C P\u00e9ladeau","year":"2018","unstructured":"P\u00e9ladeau, C., Adam, N. J. & Jasmin, B. J. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. FASEB J. 32, 5090\u20135103 (2018).","journal-title":"FASEB J."},{"key":"34831_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/mus.24692","volume":"52","author":"V Ljubicic","year":"2015","unstructured":"Ljubicic, V. & Jasmin, B. J. Metformin increases peroxisome proliferator-activated receptor \u03b3 Co-activator-1\u03b1 and utrophin a expression in dystrophic skeletal muscle. Muscle Nerve 52, 139\u2013142 (2015).","journal-title":"Muscle Nerve"},{"key":"34831_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica, P. et al. Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 26, 643\u2013649 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"34831_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0928-4257(01)00078-X","volume":"96","author":"BJ Jasmin","year":"2002","unstructured":"Jasmin, B. J. et al. Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy. J. Physiol. Paris 96, 31\u201342 (2002).","journal-title":"J. Physiol. Paris"},{"key":"34831_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/384349a0","volume":"384","author":"JM Tinsley","year":"1996","unstructured":"Tinsley, J. M. et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349\u2013353 (1996).","journal-title":"Nature"},{"key":"34831_CR30","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/S0960-8966(02)00087-1","volume":"12","author":"KJ Perkins","year":"2002","unstructured":"Perkins, K. J. & Davies, K. E. The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscul. Disord. 12, S78\u201389 (2002). Suppl 1.","journal-title":"Neuromuscul. Disord."},{"key":"34831_CR31","doi-asserted-by":"publisher","unstructured":"Manzur, A. Y., Kuntzer, T., Pike, M. & Swan, A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev CD003725 https:\/\/doi.org\/10.1002\/14651858.CD003725.pub3 (2008).","DOI":"10.1002\/14651858.CD003725.pub3"},{"key":"34831_CR32","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1101\/gad.1350705","volume":"19","author":"J Massagu\u00e9","year":"2005","unstructured":"Massagu\u00e9, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783\u20132810 (2005).","journal-title":"Genes Dev."},{"key":"34831_CR33","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1242\/jcs.113.7.1101","volume":"113","author":"K Miyazono","year":"2000","unstructured":"Miyazono, K. Positive and negative regulation of TGF-beta signaling. J. Cell Sci. 113, 1101\u20131109 (2000).","journal-title":"J. Cell Sci."},{"key":"34831_CR34","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/cells10081873","volume":"10","author":"L Cussonneau","year":"2021","unstructured":"Cussonneau, L. et al. Concurrent BMP Signaling Maintenance and TGF-\u03b2 Signaling Inhibition Is a Hallmark of Natural Resistance to Muscle Atrophy in the Hibernating Bear. Cells 10, 1873 (2021).","journal-title":"Cells"},{"key":"34831_CR35","doi-asserted-by":"publisher","first-page":"C1316","DOI":"10.1152\/ajpcell.00114.2011","volume":"301","author":"S Lokireddy","year":"2011","unstructured":"Lokireddy, S. et al. Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am. J. Physiol. Cell Physiol. 301, C1316\u20131324 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"34831_CR36","doi-asserted-by":"publisher","first-page":"12184","DOI":"10.1074\/jbc.M115.680579","volume":"291","author":"T Tando","year":"2016","unstructured":"Tando, T. et al. Smad2\/3 proteins are required for immobilization-induced skeletal muscle atrophy. J. Biol. Chem. 291, 12184\u201312194 (2016).","journal-title":"J. Biol. Chem."},{"key":"34831_CR37","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1210\/me.2013-1194","volume":"27","author":"CA Goodman","year":"2013","unstructured":"Goodman, C. A., McNally, R. M., Hoffmann, F. M. & Hornberger, T. A. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo. Mol. Endocrinol. 27, 1946\u20131957 (2013).","journal-title":"Mol. Endocrinol."},{"key":"34831_CR38","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1074\/jbc.274.4.2440","volume":"274","author":"A Verdel","year":"1999","unstructured":"Verdel, A. & Khochbin, S. Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J. Biol. Chem. 274, 2440\u20132445 (1999).","journal-title":"J. Biol. Chem."},{"key":"34831_CR39","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","volume":"96","author":"CM Grozinger","year":"1999","unstructured":"Grozinger, C. M., Hassig, C. A. & Schreiber, S. L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl Acad. Sci. USA 96, 4868\u20134873 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34831_CR40","doi-asserted-by":"publisher","first-page":"C587","DOI":"10.1152\/ajpcell.00142.2011","volume":"302","author":"E Bertaggia","year":"2012","unstructured":"Bertaggia, E., Coletto, L. & Sandri, M. Posttranslational modifications control FoxO3 activity during denervation. Am. J. Physiol., Cell Physiol. 302, C587\u2013596 (2012).","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"34831_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2010.09.004","volume":"143","author":"V Moresi","year":"2010","unstructured":"Moresi, V. et al. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143, 35\u201345 (2010).","journal-title":"Cell"},{"key":"34831_CR42","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1074\/jbc.M114.600916","volume":"290","author":"F Ratti","year":"2015","unstructured":"Ratti, F. et al. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy. J. Biol. Chem. 290, 4215\u20134224 (2015).","journal-title":"J. Biol. Chem."},{"key":"34831_CR43","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3892\/or.2012.1898","volume":"28","author":"K Kanno","year":"2012","unstructured":"Kanno, K. et al. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells. Oncol. Rep. 28, 867\u2013873 (2012).","journal-title":"Oncol. Rep."},{"key":"34831_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tranon.2019.11.001","volume":"13","author":"B Deskin","year":"2019","unstructured":"Deskin, B. et al. Inhibition of HDAC6 Attenuates Tumor Growth of Non-Small Cell Lung Cancer. Transl. Oncol. 13, 135\u2013145 (2019).","journal-title":"Transl. Oncol."},{"key":"34831_CR45","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","volume":"22","author":"I Taes","year":"2013","unstructured":"Taes, I. et al. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet 22, 1783\u20131790 (2013).","journal-title":"Hum. Mol. Genet"},{"key":"34831_CR46","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nm.2396","volume":"17","author":"C d\u2019Ydewalle","year":"2011","unstructured":"d\u2019Ydewalle, C. et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 17, 968\u2013974 (2011).","journal-title":"Nat. Med."},{"key":"34831_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 8, 861 (2017).","journal-title":"Nat. Commun."},{"key":"34831_CR48","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","volume":"132","author":"KV Butler","year":"2010","unstructured":"Butler, K. V. et al. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J. Am. Chem. Soc. 132, 10842\u201310846 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"34831_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00109-014-1202-x","volume":"93","author":"WA Gold","year":"2015","unstructured":"Gold, W. A., Lacina, T. A., Cantrill, L. C. & Christodoulou, J. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors. J. Mol. Med (Berl.) 93, 63\u201372 (2015).","journal-title":"J. Mol. Med (Berl.)"},{"key":"34831_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14983-9","volume":"7","author":"S Ehnert","year":"2017","unstructured":"Ehnert, S. et al. Extremely low frequency pulsed electromagnetic fields cause antioxidative defense mechanisms in human osteoblasts via induction of \u2022O2- and H2O2. Sci. Rep. 7, 14544 (2017).","journal-title":"Sci. Rep."},{"key":"34831_CR51","doi-asserted-by":"publisher","first-page":"e0186615","DOI":"10.1371\/journal.pone.0186615","volume":"12","author":"S Saito","year":"2017","unstructured":"Saito, S. et al. Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway. PLoS One 12, e0186615 (2017).","journal-title":"PLoS One"},{"key":"34831_CR52","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1074\/jbc.M115.713123","volume":"291","author":"S Gu","year":"2016","unstructured":"Gu, S. et al. Loss of \u03b1-tubulin acetylation is associated with TGF-\u03b2-induced epithelial-mesenchymal transition. J. Biol. Chem. 291, 5396\u20135405 (2016).","journal-title":"J. Biol. Chem."},{"key":"34831_CR53","doi-asserted-by":"publisher","unstructured":"Thakur, N. et al. Smad7 Enhances TGF-\u03b2-induced transcription of c-Jun and HDAC6 promoting invasion of prostate cancer cells. iScience 101470 https:\/\/doi.org\/10.1016\/j.isci.2020.101470 (2020).","DOI":"10.1016\/j.isci.2020.101470"},{"key":"34831_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep31086","volume":"6","author":"B Deskin","year":"2016","unstructured":"Deskin, B., Lasky, J., Zhuang, Y. & Shan, B. Requirement of HDAC6 for activation of Notch1 by TGF-\u03b21. Sci. Rep. 6, 31086 (2016).","journal-title":"Sci. Rep."},{"key":"34831_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03842-1","volume":"12","author":"T Zhang","year":"2021","unstructured":"Zhang, T. et al. HDAC6 regulates primordial follicle activation through mTOR signaling pathway. Cell Death Dis. 12, 559 (2021).","journal-title":"Cell Death Dis."},{"key":"34831_CR56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti, G. C. et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12, 1147\u20131150 (2006).","journal-title":"Nat. Med."},{"key":"34831_CR57","doi-asserted-by":"crossref","unstructured":"Osseni, A. et al. HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions. J. Cell Biol. 219 (2020).","DOI":"10.1083\/jcb.201901099"},{"key":"34831_CR58","doi-asserted-by":"publisher","unstructured":"Ota, S., Zhou, Z.-Q., Romero, M. P., Yang, G. & Hurlin, P. J. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddw255 (2016).","DOI":"10.1093\/hmg\/ddw255"},{"key":"34831_CR59","doi-asserted-by":"publisher","first-page":"e19189","DOI":"10.1371\/journal.pone.0019189","volume":"6","author":"JM Tinsley","year":"2011","unstructured":"Tinsley, J. M. et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One 6, e19189 (2011).","journal-title":"PLoS One"},{"key":"34831_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-16","volume":"2","author":"VE Jahnke","year":"2012","unstructured":"Jahnke, V. E. et al. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2, 16 (2012).","journal-title":"Skelet. Muscle"},{"key":"34831_CR61","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1093\/hmg\/ddp431","volume":"18","author":"P Miura","year":"2009","unstructured":"Miura, P. et al. Pharmacological activation of PPARbeta\/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Hum. Mol. Genet 18, 4640\u20134649 (2009).","journal-title":"Hum. Mol. Genet"},{"key":"34831_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep43697","volume":"7","author":"S Guiraud","year":"2017","unstructured":"Guiraud, S. et al. Identification of serum protein biomarkers for utrophin based DMD therapy. Sci. Rep. 7, 43697 (2017).","journal-title":"Sci. Rep."},{"key":"34831_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15971-w","volume":"11","author":"C P\u00e9ladeau","year":"2020","unstructured":"P\u00e9ladeau, C. et al. Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles. Nat. Commun. 11, 1990 (2020).","journal-title":"Nat. Commun."},{"key":"34831_CR64","first-page":"197","volume":"311","author":"M Fardeau","year":"1990","unstructured":"Fardeau, M. et al. [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in \u2018mdx\u2019 mutant mice]. C. R. Acad. Sci. III 311, 197\u2013204 (1990).","journal-title":"C. R. Acad. Sci. III"},{"key":"34831_CR65","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","volume":"7","author":"K Ohlendieck","year":"1991","unstructured":"Ohlendieck, K. et al. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7, 499\u2013508 (1991).","journal-title":"Neuron"},{"key":"34831_CR66","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.273.2.736","volume":"273","author":"AO Gramolini","year":"1998","unstructured":"Gramolini, A. O. et al. Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. J. Biol. Chem. 273, 736\u2013743 (1998).","journal-title":"J. Biol. Chem."},{"key":"34831_CR67","first-page":"209","volume":"24","author":"RC Hirst","year":"2005","unstructured":"Hirst, R. C., McCullagh, K. J. A. & Davies, K. E. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol. 24, 209\u2013216 (2005).","journal-title":"Acta Myol."},{"key":"34831_CR68","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrg3460","volume":"14","author":"RJ Fairclough","year":"2013","unstructured":"Fairclough, R. J., Wood, M. J. & Davies, K. E. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat. Rev. Genet. 14, 373\u2013378 (2013).","journal-title":"Nat. Rev. Genet"},{"key":"34831_CR69","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/febs.12267","volume":"280","author":"TA Partridge","year":"2013","unstructured":"Partridge, T. A. The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J. 280, 4177\u20134186 (2013).","journal-title":"FEBS J."},{"key":"34831_CR70","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley, J. et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med. 4, 1441\u20131444 (1998).","journal-title":"Nat. Med."},{"key":"34831_CR71","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1371\/journal.pone.0002309","volume":"3","author":"P Miura","year":"2008","unstructured":"Miura, P., Andrews, M., Holcik, M. & Jasmin, B. J. IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells. PLoS One 3, e2309 (2008).","journal-title":"PLoS One"},{"key":"34831_CR72","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0430973100","volume":"100","author":"SJ Haggarty","year":"2003","unstructured":"Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M. & Schreiber, S. L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. USA 100, 4389\u20134394 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"34831_CR73","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","volume":"14","author":"A Briguet","year":"2004","unstructured":"Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. & Magyar, J. P. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675\u2013682 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"34831_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/110.2.269","volume":"110","author":"LF Torres","year":"1987","unstructured":"Torres, L. F. & Duchen, L. W. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110, 269\u2013299 (1987). (Pt 2).","journal-title":"Brain"},{"key":"34831_CR75","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/jcsm.12338","volume":"9","author":"J Gonz\u00e1lez-S\u00e1nchez","year":"2018","unstructured":"Gonz\u00e1lez-S\u00e1nchez, J. et al. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment. J. Cachexia Sarcopenia Muscle 9, 1063\u20131078 (2018).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"34831_CR76","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1073\/pnas.1323842111","volume":"111","author":"JJ Belanto","year":"2014","unstructured":"Belanto, J. J. et al. Microtubule binding distinguishes dystrophin from utrophin. Proc. Natl. Acad. Sci. USA 111, 5723\u20135728 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"34831_CR77","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.2002829","volume":"5","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah, R. J. et al. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci. Signal 5, ra56 (2012).","journal-title":"Sci. Signal"},{"key":"34831_CR78","doi-asserted-by":"publisher","first-page":"10694","DOI":"10.1523\/JNEUROSCI.19-24-10694.1999","volume":"19","author":"E Ralston","year":"1999","unstructured":"Ralston, E., Lu, Z. & Ploug, T. The organization of the Golgi complex and microtubules in skeletal muscle is fiber type-dependent. J. Neurosci. 19, 10694\u201310705 (1999).","journal-title":"J. Neurosci."},{"key":"34831_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1083\/jcb.201304063","volume":"203","author":"S Oddoux","year":"2013","unstructured":"Oddoux, S. et al. Microtubules that form the stationary lattice of muscle fibers are dynamic and nucleated at Golgi elements. J. Cell Biol. 203, 205\u2013213 (2013).","journal-title":"J. Cell Biol."},{"key":"34831_CR80","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1242\/jcs.188862","volume":"129","author":"A Osseni","year":"2016","unstructured":"Osseni, A. et al. Triadin and CLIMP-63 form a link between triads and microtubules in muscle cells. J. Cell. Sci. 129, 3744\u20133755 (2016).","journal-title":"J. Cell. Sci."},{"key":"34831_CR81","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cm.21166","volume":"71","author":"W Liu","year":"2014","unstructured":"Liu, W. & Ralston, E. A new directionality tool for assessing microtubule pattern alterations. Cytoskeleton (Hoboken) 71, 230\u2013240 (2014).","journal-title":"Cytoskeleton (Hoboken)"},{"key":"34831_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ncb3481","volume":"19","author":"D Portran","year":"2017","unstructured":"Portran, D., Schaedel, L., Xu, Z., Th\u00e9ry, M. & Nachury, M. V. Tubulin acetylation protects long-lived microtubules against mechanical ageing. Nat. Cell Biol. 19, 391\u2013398 (2017).","journal-title":"Nat. Cell Biol."},{"key":"34831_CR83","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0006-8993(99)01737-0","volume":"839","author":"J Kong","year":"1999","unstructured":"Kong, J. & Anderson, J. E. Dystrophin is required for organizing large acetylcholine receptor aggregates. Brain Res. 839, 298\u2013304 (1999).","journal-title":"Brain Res"},{"key":"34831_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mus.20697","volume":"35","author":"MJ Marques","year":"2007","unstructured":"Marques, M. J., Ferretti, R., Vomero, V. U., Minatel, E. & Neto, H. S. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 35, 349\u2013353 (2007).","journal-title":"Muscle Nerve"},{"key":"34831_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00018-014-1663-7","volume":"72","author":"SJP Pratt","year":"2015","unstructured":"Pratt, S. J. P. et al. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury. Cell. Mol. Life Sci. 72, 153\u2013164 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"34831_CR86","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/ejn.13249","volume":"43","author":"EM van der Pijl","year":"2016","unstructured":"van der Pijl, E. M. et al. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. Eur. J. Neurosci. 43, 1623\u20131635 (2016).","journal-title":"Eur. J. Neurosci."},{"key":"34831_CR87","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.200903131","volume":"187","author":"V Risson","year":"2009","unstructured":"Risson, V. et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187, 859\u2013874 (2009).","journal-title":"J. Cell Biol."},{"key":"34831_CR88","doi-asserted-by":"publisher","first-page":"e0207285","DOI":"10.1371\/journal.pone.0207285","volume":"13","author":"F Das","year":"2018","unstructured":"Das, F. et al. Akt2 causes TGF\u03b2-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression. PLOS ONE 13, e0207285 (2018).","journal-title":"PLOS ONE"},{"key":"34831_CR89","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","volume":"280","author":"S Schiaffino","year":"2013","unstructured":"Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B. & Sandri, M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 280, 4294\u20134314 (2013).","journal-title":"FEBS J."},{"key":"34831_CR90","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10522-013-9432-9","volume":"14","author":"M Sandri","year":"2013","unstructured":"Sandri, M. et al. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 14, 303\u2013323 (2013).","journal-title":"Biogerontology"},{"key":"34831_CR91","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling. Nature 425, 577\u2013584 (2003).","journal-title":"Nature"},{"key":"34831_CR92","doi-asserted-by":"publisher","first-page":"21187","DOI":"10.1074\/jbc.M700085200","volume":"282","author":"AW Tu","year":"2007","unstructured":"Tu, A. W. & Luo, K. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response. J. Biol. Chem. 282, 21187\u201321196 (2007).","journal-title":"J. Biol. Chem."},{"key":"34831_CR93","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.onc.1209826","volume":"26","author":"Y Inoue","year":"2007","unstructured":"Inoue, Y. et al. Smad3 is acetylated by p300\/CBP to regulate its transactivation activity. Oncogene 26, 500\u2013508 (2007).","journal-title":"Oncogene"},{"key":"34831_CR94","doi-asserted-by":"publisher","first-page":"e15511","DOI":"10.1371\/journal.pone.0015511","volume":"5","author":"C Krueger","year":"2010","unstructured":"Krueger, C. & Hoffmann, F. M. Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1. PLoS One 5, e15511 (2010).","journal-title":"PLoS One"},{"key":"34831_CR95","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood.V92.10.3647","volume":"92","author":"H Yu","year":"1998","unstructured":"Yu, H. et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 92, 3647\u20133657 (1998).","journal-title":"Blood"},{"key":"34831_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91102-9","volume":"11","author":"S Ishikawa","year":"2021","unstructured":"Ishikawa, S. et al. Comprehensive profiling of novel epithelial-mesenchymal transition mediators and their clinical significance in colorectal cancer. Sci. Rep. 11, 11759 (2021).","journal-title":"Sci. Rep."},{"key":"34831_CR97","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3389\/fphys.2019.01606","volume":"10","author":"M Han","year":"2019","unstructured":"Han, M. et al. Caveolin-1 Impacts on TGF-\u03b2 Regulation of Metabolic Gene Signatures in Hepatocytes. Front Physiol. 10, 1606 (2019).","journal-title":"Front Physiol."},{"key":"34831_CR98","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1111\/febs.12266","volume":"280","author":"E Ceco","year":"2013","unstructured":"Ceco, E. & McNally, E. M. Modifying muscular dystrophy through transforming growth factor-\u03b2. FEBS J. 280, 4198\u20134209 (2013).","journal-title":"FEBS J."},{"key":"34831_CR99","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1038\/s41388-021-01974-4","volume":"40","author":"DJ Garc\u00eda-Dom\u00ednguez","year":"2021","unstructured":"Garc\u00eda-Dom\u00ednguez, D. J. et al. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma. Oncogene 40, 5843\u20135853 (2021).","journal-title":"Oncogene"},{"key":"34831_CR100","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1158\/1078-0432.CCR-04-0455","volume":"10","author":"Z Zhang","year":"2004","unstructured":"Zhang, Z. et al. HDAC6 expression is correlated with better survival in breast cancer. Clin. Cancer Res. 10, 6962\u20136968 (2004).","journal-title":"Clin. Cancer Res."},{"key":"34831_CR101","doi-asserted-by":"publisher","first-page":"C571","DOI":"10.1152\/ajpcell.00087.2009","volume":"297","author":"RM Lovering","year":"2009","unstructured":"Lovering, R. M., Michaelson, L. & Ward, C. W. Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am. J. Physiol. Cell Physiol. 297, C571\u2013580 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"34831_CR102","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1113\/jphysiol.2012.241679","volume":"591","author":"SJP Pratt","year":"2013","unstructured":"Pratt, S. J. P. et al. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles. J. Physiol. 591, 559\u2013570 (2013).","journal-title":"J. Physiol."},{"key":"34831_CR103","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1083\/jcb.150.6.1385","volume":"150","author":"ME Adams","year":"2000","unstructured":"Adams, M. E. et al. Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J. Cell Biol. 150, 1385\u20131398 (2000).","journal-title":"J. Cell Biol."},{"key":"34831_CR104","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","volume":"40","author":"GB Banks","year":"2009","unstructured":"Banks, G. B., Chamberlain, J. S. & Froehner, S. C. Truncated dystrophins can influence neuromuscular synapse structure. Mol. Cell Neurosci. 40, 433\u2013441 (2009).","journal-title":"Mol. Cell Neurosci."},{"key":"34831_CR105","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","volume":"15","author":"KA Kleopa","year":"2006","unstructured":"Kleopa, K. A., Drousiotou, A., Mavrikiou, E., Ormiston, A. & Kyriakides, T. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. Hum. Mol. Genet 15, 1623\u20131628 (2006).","journal-title":"Hum. Mol. Genet"},{"key":"34831_CR106","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.vph.2015.04.006","volume":"72","author":"SY Choi","year":"2015","unstructured":"Choi, S. Y. et al. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. Vasc. Pharm. 72, 130\u2013140 (2015).","journal-title":"Vasc. Pharm."},{"key":"34831_CR107","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","volume":"6","author":"S Iezzi","year":"2004","unstructured":"Iezzi, S. et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell 6, 673\u2013684 (2004).","journal-title":"Dev. Cell"},{"key":"34831_CR108","doi-asserted-by":"publisher","first-page":"135703","DOI":"10.1172\/jci.insight.135703","volume":"5","author":"DA M\u00e1zala","year":"2020","unstructured":"M\u00e1zala, D. A. et al. TGF-\u03b2-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. JCI Insight 5, 135703 (2020).","journal-title":"JCI Insight"},{"key":"34831_CR109","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymthe.2020.09.029","volume":"29","author":"F Yue","year":"2021","unstructured":"Yue, F. et al. PTEN inhibition ameliorates muscle degeneration and improves muscle function in a mouse model of duchenne muscular dystrophy. Mol. Ther. 29, 132\u2013148 (2021).","journal-title":"Mol. Ther."},{"key":"34831_CR110","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/31693","volume":"393","author":"M Nomura","year":"1998","unstructured":"Nomura, M. & Li, E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393, 786\u2013790 (1998).","journal-title":"Nature"},{"key":"34831_CR111","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)81407-5","volume":"92","author":"WR Waldrip","year":"1998","unstructured":"Waldrip, W. R., Bikoff, E. K., Hoodless, P. A., Wrana, J. L. & Robertson, E. J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92, 797\u2013808 (1998).","journal-title":"Cell"},{"key":"34831_CR112","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1128\/MCB.19.4.2495","volume":"19","author":"MB Datto","year":"1999","unstructured":"Datto, M. B. et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell Biol. 19, 2495\u20132504 (1999).","journal-title":"Mol. Cell Biol."},{"key":"34831_CR113","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/emboj\/18.5.1280","volume":"18","author":"X Yang","year":"1999","unstructured":"Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18, 1280\u20131291 (1999).","journal-title":"EMBO J."},{"key":"34831_CR114","doi-asserted-by":"publisher","first-page":"39870","DOI":"10.1074\/jbc.M607868200","volume":"281","author":"M Simonsson","year":"2006","unstructured":"Simonsson, M., Kanduri, M., Gr\u00f6nroos, E., Heldin, C.-H. & Ericsson, J. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J. Biol. Chem. 281, 39870\u201339880 (2006).","journal-title":"J. Biol. Chem."},{"key":"34831_CR115","doi-asserted-by":"publisher","first-page":"21065","DOI":"10.1074\/jbc.M802786200","volume":"283","author":"B Shan","year":"2008","unstructured":"Shan, B. et al. Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. J. Biol. Chem. 283, 21065\u201321073 (2008).","journal-title":"J. Biol. Chem."},{"key":"34831_CR116","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1097-2765(00)80400-1","volume":"5","author":"C Dong","year":"2000","unstructured":"Dong, C., Li, Z., Alvarez, R., Feng, X. H. & Goldschmidt-Clermont, P. J. Microtubule binding to Smads may regulate TGF beta activity. Mol. Cell 5, 27\u201334 (2000).","journal-title":"Mol. Cell"},{"key":"34831_CR117","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/01.RES.0000118599.25944.D5","volume":"94","author":"S Zhu","year":"2004","unstructured":"Zhu, S., Goldschmidt-Clermont, P. J. & Dong, C. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability. Circ. Res. 94, 617\u2013625 (2004).","journal-title":"Circ. Res"},{"key":"34831_CR118","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1091\/mbc.e06-12-1064","volume":"18","author":"P Dai","year":"2007","unstructured":"Dai, P., Nakagami, T., Tanaka, H., Hitomi, T. & Takamatsu, T. Cx43 mediates TGF-beta signaling through competitive Smads binding to microtubules. Mol. Biol. Cell 18, 2264\u20132273 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"34831_CR119","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","volume":"74","author":"YS Gallot","year":"2014","unstructured":"Gallot, Y. S. et al. Myostatin gene inactivation prevents skeletal muscle wasting in cancer. Cancer Res. 74, 7344\u20137356 (2014).","journal-title":"Cancer Res."},{"key":"34831_CR120","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/jcsm.12441","volume":"10","author":"JDCC Lima","year":"2019","unstructured":"Lima, J. D. C. C. et al. Tumour-derived transforming growth factor-\u03b2 signalling contributes to fibrosis in patients with cancer cachexia. J. Cachexia Sarcopenia Muscle 10, 1045\u20131059 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"34831_CR121","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/0886022X.2020.1811119","volume":"42","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis. Ren. Fail 42, 890\u2013901 (2020).","journal-title":"Ren. Fail"},{"key":"34831_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50385-9","volume":"9","author":"A Chopra","year":"2019","unstructured":"Chopra, A., Willmore, W. G. & Biggar, K. K. Protein quantification and visualization via ultraviolet-dependent labeling with 2,2,2-trichloroethanol. Sci. Rep. 9, 13923 (2019).","journal-title":"Sci. Rep."},{"key":"34831_CR123","doi-asserted-by":"crossref","unstructured":"Jones, R. A. et al. NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction. Open Biol. 6, 160240 (2016).","DOI":"10.1098\/rsob.160240"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34831-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T23:52:00Z","timestamp":1728431520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34831"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34831-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7108"}}